What Predicts the Success of Alcohol Septal Ablation?: The Myocardium Counts, After All.

Massera, Daniele; Sherrid, Mark V

Massera, Daniele; Sherrid, Mark V.

Affiliation

Massera D; Hypertrophic Cardiomyopathy Program, Leon H. Charney Division of Cardiology, NYU Langone Health and NYU Grossman School of Medicine.
Sherrid MV; Hypertrophic Cardiomyopathy Program, Leon H. Charney Division of Cardiology, NYU Langone Health and NYU Grossman School of Medicine.

Circ Cardiovasc Interv ; 16(8): e013402, 2023 08.

Article in En | MEDLINE | ID: mdl-37582171

Subject(s)

Cardiac Surgical Procedures; Cardiomyopathy, Hypertrophic; Catheter Ablation; Humans; Treatment Outcome; Myocardium; Cardiomyopathy, Hypertrophic/diagnostic imaging; Cardiomyopathy, Hypertrophic/surgery

Key words

Editorials; cardiomyopathy, hypertrophic; follow-up studies; mitral valve; quality of life

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiomyopathy, Hypertrophic / Catheter Ablation / Cardiac Surgical Procedures Type of study: Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2023 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google